Table 3 Vascular events, wound complications, and adverse reactions resulting from TXA
Variable | Control group (30 patients) | i.v. group (30 patients) | Topical group (30 patients) | P value (between groups) |
|---|---|---|---|---|
Vascular events | ||||
 DVT | 3 | 5 | 3 | 0.661 |
 MI | 0 | 0 | 0 | – |
 CI | 0 | 0 | 0 | – |
 PE | 0 | 0 | 0 | – |
 GIH | 0 | 1 | 0 | 0.364 |
 Total | 3 | 6 | 3 | 0.421 |
Wound complications | ||||
 Dehiscence | 0 | 0 | 0 | – |
 Hematoma | 0 | 0 | 0 | – |
 Edge necrosis | 0 | 0 | 0 | – |
 Infection | 1 | 0 | 0 | 0.364 |
 Total | 1 | 0 | 0 | 0.364 |
Adverse reactions | ||||
 Epilepsy | 0 | 0 | 0 | – |
 Rash | 0 | 1 | 0 | 0.364 |
 Headache | 2 | 4 | 1 | 0.338 |
 Nausea and Vomiting | 1 | 1 | 1 | 1.000 |
 Total | 3 | 6 | 2 | 0.260 |